Bringing the fundamentals into focus…
Back to X4 Pharmaceuticals, Inc.
How X4 Pharmaceuticals, Inc. stacks up
XFOR · against 371 other Healthcare companies of similar size
Profitability
6/ 100
Near the bottom of its peers.
Ranked #344 of 372 · scores higher than 7% of peers
Bars: peers in each 10-point band of the profitability score45 peers with a profitability score of 0–9, including XFOR · Click a bar to see the companies
Why profitability scores 6?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital, operating margin and return on assets, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 96% of peers. Return on invested capital: -196.4% vs peer median 4.7%
- a thinner operating margin: weaker than 93% of peers. Operating margin: -554.7% vs peer median 7.1%
- a lower return on assets: weaker than 89% of peers. Return on assets: -35.6% vs peer median 1.7%
Metric by metric
Position: dot = XFOR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | XFOR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 336 reported | -196.4% | 0.5% | 5% | 33% | |
| Operating marginHigher is better · 346 reported | -554.7% | 3.0% | 7% | 33% | |
| Return on assetsHigher is better · 370 reported | -35.6% | -0.1% | 13% | 33% | |
| Return on equityHigher is better · 349 reported | -113.1% | -0.7% | 6% | Context only | |
| Gross marginHigher is better · 387 reported | 81.5% | 38.1% | 88% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around XFOR| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 609M USD | 99 | 91 | |
| 5 | 4.4B CNY (≈$611M) | 98 | 77 | |
| 340 | 158M USD | 7 | 14 | |
| 344 | 13.0B TWD (≈$402M) | 6 | 49 | |
| 344 | 4.6B SEK (≈$462M) | 6 | 37 | |
| 344 | 354M USD | 6 | 13 | |
| 344 | 314M USD | 6 | 56 | |
| 348 | 397M USD | 5 | 37 | |
| 348 | 389M USD | 5 | 33 | |
| 348 | 274M USD | 5 | 57 | |
| 348 | 327M USD | 5 | 11 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score